• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Genetic Diversity of SARS-CoV-2 among Travelers Arriving in Hong Kong

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Oct;27(10):2666-2668.
doi: 10.3201/eid2710.211028.
Genetic Diversity of SARS-CoV-2 among Travelers Arriving in Hong Kong

Haogao Gu, Daniel K W Chu, Lydia D J Chang, Sammi S Y Cheuk, Shreya Gurung, Pavithra Krishnan, Daisy Y M Ng, Gigi Y Z Liu, Carrie K C Wan, Ruopeng Xie, Samuel S M Cheng, Benjamin J Cowling, Dominic N C Tsang, Malik Peiris, Vijaykrishna Dhanasekaran, Leo L M Poon

Abstract

We sequenced 10% of imported severe acute respiratory syndrome coronavirus 2 infections detected in travelers to Hong Kong and revealed the genomic diversity of regions of origin, including lineages not previously reported from those countries. Our results suggest that international or regional travel hubs might be useful surveillance sites to monitor sequence diversity.

Keywords: COVID-19; SARS-COV-2; coronavirus disease; disease transmission control; genomic diversity; public health; public health readiness; respiratory infections; reverse transcription PCR; severe acute respiratory syndrome coronavirus 2; travel-related disease transmission; viruses; zoonoses.
 
Back
Top Bottom